JP Morgan Chase’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08B | Buy |
22,783,175
+1,038,463
| +5% | +$87M | 0.12% | 169 |
|
|
2026
Q1 | $1.73B | Sell |
21,744,712
-4,280,140
| -16% | -$353M | 0.11% | 182 |
|
|
2025
Q4 | $2.22B | Buy |
26,024,852
+966,326
| +4% | +$79.3M | 0.14% | 156 |
|
|
2025
Q3 | $1.95B | Sell |
25,058,526
-1,714,961
| -6% | -$134M | 0.12% | 172 |
|
|
2025
Q2 | $2.09B | Buy |
26,773,487
+4,811,521
| +22% | +$359M | 0.14% | 149 |
|
|
2025
Q1 | $1.59B | Buy |
21,961,966
+7,110,139
| +48% | +$509M | 0.12% | 178 |
|
|
2024
Q4 | $1.1B | Buy |
14,851,827
+6,385,779
| +75% | +$447M | 0.08% | 229 |
|
|
2024
Q3 | $559M | Sell |
8,466,048
-212,869
| -2% | -$15.5M | 0.04% | 361 |
|
|
2024
Q2 | $802M | Sell |
8,678,917
-922,139
| -10% | -$81.7M | 0.07% | 266 |
|
|
2024
Q1 | $917M | Buy |
9,601,056
+1,770,391
| +23% | +$149M | 0.08% | 247 |
|
|
2023
Q4 | $597M | Buy |
7,830,665
+4,332,955
| +124% | +$301M | 0.06% | 314 |
|
|
2023
Q3 | $242M | Buy |
3,497,710
+317,229
| +10% | +$25.5M | 0.03% | 501 |
|
|
2023
Q2 | $300M | Buy |
3,180,481
+767,847
| +32% | +$66.7M | 0.03% | 448 |
|
|
2023
Q1 | $200M | Buy |
2,412,634
+587,461
| +32% | +$46.2M | 0.02% | 546 |
|
|
2022
Q4 | $136M | Sell |
1,825,173
-196,581
| -10% | -$15.2M | 0.02% | 653 |
|
|
2022
Q3 | $167M | Buy |
2,021,754
+50,418
| +3% | +$4.85M | 0.02% | 541 |
|
|
2022
Q2 | $187M | Buy |
1,971,336
+671,264
| +52% | +$69.5M | 0.03% | 528 |
|
|
2022
Q1 | $153M | Buy |
1,300,072
+199,094
| +18% | +$22.3M | 0.02% | 662 |
|
|
2021
Q4 | $143M | Sell |
1,100,978
-10,693
| -1% | -$1.25M | 0.02% | 710 |
|
|
2021
Q3 | $126M | Sell |
1,111,671
-41,284
| -4% | -$4.71M | 0.02% | 761 |
|
|
2021
Q2 | $119M | Sell |
1,152,955
-664,028
| -37% | -$62.6M | 0.01% | 815 |
|
|
2021
Q1 | $152M | Buy |
1,816,983
+60,439
| +3% | +$5.11M | 0.02% | 666 |
|
|
2020
Q4 | $160M | Buy |
1,756,544
+38,508
| +2% | +$3.19M | 0.02% | 605 |
|
|
2020
Q3 | $135M | Buy |
1,718,036
+298,153
| +21% | +$23.3M | 0.02% | 593 |
|
|
2020
Q2 | $98.1M | Sell |
1,419,883
-1,013,537
| -42% | -$72M | 0.02% | 660 |
|
|
2020
Q1 | $153M | Buy |
2,433,420
+1,371,828
| +129% | +$98.9M | 0.04% | 450 |
|
|
2019
Q4 | $82.6M | Buy |
1,061,592
+76,857
| +8% | +$6M | 0.02% | 745 |
|
|
2019
Q3 | $72.2M | Sell |
984,735
-243,603
| -20% | -$17.1M | 0.01% | 785 |
|
|
2019
Q2 | $75.9M | Sell |
1,228,338
-1,017,993
| -45% | -$61.6M | 0.01% | 777 |
|
|
2019
Q1 | $143M | Buy |
2,246,331
+23,025
| +1% | +$1.31M | 0.03% | 533 |
|
|
2018
Q4 | $114M | Buy |
2,223,306
+17,025
| +0.8% | +$861K | 0.03% | 581 |
|
|
2018
Q3 | $128M | Sell |
2,206,281
-158,907
| -7% | -$7.77M | 0.02% | 593 |
|
|
2018
Q2 | $115M | Buy |
2,365,188
+649,779
| +38% | +$30.3M | 0.02% | 604 |
|
|
2018
Q1 | $79.8M | Sell |
1,715,409
-195,768
| -10% | -$8.5M | 0.02% | 725 |
|
|
2017
Q4 | $71.8M | Buy |
1,911,177
+217,986
| +13% | +$8M | 0.02% | 801 |
|
|
2017
Q3 | $61.4M | Buy |
1,693,191
+100,041
| +6% | +$3.82M | 0.01% | 817 |
|
|
2017
Q2 | $62.8M | Sell |
1,593,150
-24,363
| -2% | -$889K | 0.01% | 809 |
|
|
2017
Q1 | $50.7M | Sell |
1,617,513
-397,518
| -20% | -$12.4M | 0.01% | 943 |
|
|
2016
Q4 | $62.9M | Sell |
2,015,031
-688,455
| -25% | -$22.3M | 0.02% | 776 |
|
|
2016
Q3 | $109M | Sell |
2,703,486
-555,282
| -17% | -$20.9M | 0.03% | 532 |
|
|
2016
Q2 | $108M | Buy |
3,258,768
+238,431
| +8% | +$8.16M | 0.03% | 538 |
|
|
2016
Q1 | $88.8M | Buy |
3,020,337
+412,374
| +16% | +$11.4M | 0.02% | 575 |
|
|
2015
Q4 | $68.7M | Buy |
2,607,963
+90,897
| +4% | +$2.36M | 0.02% | 682 |
|
|
2015
Q3 | $59.6M | Sell |
2,517,066
-17,856
| -0.7% | -$431K | 0.02% | 714 |
|
|
2015
Q2 | $60.2M | Buy |
2,534,922
+428,052
| +20% | +$9.66M | 0.01% | 804 |
|
|
2015
Q1 | $50M | Sell |
2,106,870
-615,546
| -23% | -$13.8M | 0.01% | 898 |
|
|
2014
Q4 | $57.8M | Sell |
2,722,416
-1,224,084
| -31% | -$24.6M | 0.01% | 868 |
|
|
2014
Q3 | $67.2M | Buy |
3,946,500
+3,195,300
| +425% | +$50.4M | 0.02% | 777 |
|
|
2014
Q2 | $10.7M | Sell |
751,200
-1,758,990
| -70% | -$23.8M | ﹤0.01% | 1702 |
|
|
2014
Q1 | $31M | Buy |
2,510,190
+955,068
| +61% | +$11M | 0.01% | 1075 |
|
|
2013
Q4 | $17M | Sell |
1,555,122
-465,192
| -23% | -$5.24M | ﹤0.01% | 1430 |
|
|
2013
Q3 | $23.4M | Sell |
2,020,314
-11,868
| -0.6% | -$139K | 0.01% | 1235 |
|
|
2013
Q2 | $22.8M | Buy |
+2,032,182
| New | +$24.1M | 0.01% | 1177 |
|
Other funds holding EW
JP Morgan Chase's EW Position: Q2 2026 in Review
JP Morgan Chase increased its Edwards Lifesciences (EW) stake by 4.8% in Q2 2026, buying an estimated $87M and bringing the position to 22,783,175 shares worth $2.08B. The position accounts for 0.12% of the portfolio, ranked #169.
JP Morgan Chase first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.22B in Q4 2025. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- JP Morgan Chase held 22,783,175 shares of Edwards Lifesciences worth $2.08B as of Q2 2026.
- JP Morgan Chase bought 1,038,463 Edwards Lifesciences shares in Q2 2026, an estimated $87M.
- Edwards Lifesciences made up 0.12% of JP Morgan Chase's portfolio in Q2 2026, its #169 holding.
- JP Morgan Chase first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Edwards Lifesciences position peaked at $2.22B in Q4 2025.
- 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.